Rhodiola rosea: a therapeutic candidate on cardiovascular diseases

Y Chen, M Tang, S Yuan, S Fu, Y Li, Y Li… - Oxidative Medicine …, 2022 - Wiley Online Library
Cardiovascular diseases, also known as circulatory diseases, are diseases of the heart and
blood vessels, and its etiology is hyperlipidemia, thick blood, atherosclerosis, and …

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy

H Sun, D Chen, W Xin, L Ren, Q Li… - Frontiers in pharmacology, 2023 - frontiersin.org
Cardiomyopathies are a clinically heterogeneous group of cardiac diseases characterized
by heart muscle damage, resulting in myocardium disorders, diminished cardiac function …

Salidroside pretreatment alleviates PM2. 5 caused lung injury via inhibition of apoptosis and pyroptosis through regulating NLRP3 Inflammasome

S Shi, D Huang, Y Wu, C Pei, Y Wang, Z Shen… - Food and Chemical …, 2023 - Elsevier
Ambient fine particulate matter (PM 2.5) is considered a leading cause of pathogenic
particulate matter induced lung injury. And Salidroside (Sal), the major bioactive constituent …

Salidroside alleviates renal fibrosis in SAMP8 mice by inhibiting ferroptosis

S Yang, T Pei, L Wang, Y Zeng, W Li, S Yan, W Xiao… - Molecules, 2022 - mdpi.com
Renal fibrosis progression is closely associated with aging, which ultimately leads to renal
dysfunction. Salidroside (SAL) is considered to have broad anti-aging effects. However, the …

Salidroside attenuates myocardial remodeling in DOCA-salt-induced mice by inhibiting the endothelin 1 and PI3K/AKT/NFκB signaling pathways

Q Liu, Q Luo, B Zhong, K Tang, X Chen, S Yang… - European Journal of …, 2024 - Elsevier
Myocardial remodeling, which occurs in the final stage of cardiovascular diseases such as
hypertension, can ultimately result in heart failure. However, the pathogenesis of myocardial …

[HTML][HTML] The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and …

M Yan, S Liu, W Zeng, Q Guo, Y Mei, X Shao… - Biomedicine & …, 2023 - Elsevier
Diabetic cardiomyopathy (DCM) is an important complication leading to the death of patients
with diabetes, but there is no effective strategy for clinical treatments. Fufang Zhenzhu …

Mechanisms and efficacy of traditional Chinese medicine in heart failure

A Wang, W Zhao, K Yan, P Huang, H Zhang… - Frontiers in …, 2022 - frontiersin.org
Heart failure (HF) is one of the main public health problems at present. Although some
breakthroughs have been made in the treatment of HF, the mortality rate remains very high …

Diabetes cardiomyopathy: targeted regulation of mitochondrial dysfunction and therapeutic potential of plant secondary metabolites

X Pan, E Hao, F Zhang, W Wei, Z Du, G Yan… - Frontiers in …, 2024 - frontiersin.org
Diabetic cardiomyopathy (DCM) is a specific heart condition in diabetic patients, which is a
major cause of heart failure and significantly affects quality of life. DCM is manifested as …

Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases

P Zhou, Y Ma, X Zhao, F Hua - Inflammopharmacology, 2023 - Springer
Cardiovascular diseases (CVDs) are currently the major cause of death and morbidity on a
global scale. Thioredoxin-interacting protein (TXNIP) is a marker related to metabolism …

The beneficial effects of chinese herbal monomers on ameliorating diabetic cardiomyopathy via Nrf2 signaling

Y Gao, W Liu, X Su, X Li, F Yu… - Oxidative Medicine and …, 2022 - Wiley Online Library
Diabetic cardiomyopathy (DCM) is the main factor responsible for poor prognosis and
survival in patients with diabetes. The highly complex pathogenesis of DCM involves …